AxoGen, Inc.

AXGN
NASDAQ
Company profile


Market capSmall (0.68B)
Company CEOKaren L. Zaderej

AxoGen, Inc.

AXGN
NASDAQ
Company profile


Market capSmall (0.68B)
Company CEOKaren L. Zaderej
$17.19Price snapshot
-Annual dividend
N/ADividend yield
UnknownDividend growth (3y)
N/ATraling P/E
-Forward P/E
-Payout ratio
-EPS

AXGN DIVIDEND PAYOUT HISTORY

Loading...

AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator.

The company was founded in 1977 and is headquartered in Alachua, FL.

PRICE HISTORY AxoGen, Inc.

Loading price stock history...

AxoGen, Inc. latest news

Loading latest news...